January 19, 2023
In a phase I clinical trial of a drug combination that aims to prevent metastatic tumors from recurring in the brains of women with advanced breast cancer, 83 percent of patients developed no new brain metastases. Trial participants, who had HER2-positive breast cancer and had previously been treated with radiation or surgery to eliminate metastatic tumors in the brain, received a combination of low-dose temozolomide (TMZ) and T-DM1. Results of the phase I study, which included 12 participants who were followed for three to 34 months, appeared January 27, 2023 in Clinical Cancer Research.
January 12, 2023
Purdue University researchers are saving women around the world. They are developing a low-cost, point-of-care paper test that could greatly change cervical cancer detection worldwide.
January 11, 2023
The initial treatment used for some younger women with an aggressive form of breast cancer may be about to change, based on results of a new clinical trial.
A Safer, Better Treatment Option for Some Younger Women with Breast Cancer
January 9, 2023
New smart soft contact lens technology developed by a multidisciplinary team of engineers and health care researchers at Purdue University and Indiana University School of Optometry looks to gather important intraocular pressure measurements for 24-hour cycles as a way to detect glaucoma. A company called BVS Sight Inc. has been launched to develop the technology.
December 23, 2022
A genetic test that reveals chromosomal abnormalities in fetuses can also detect DNA released by cancer cells.
A new kind of blood test can screen for many cancers — as some pregnant people learn
December 20, 2022
Low- and middle-income countries have more than 80% of the world's cervical cancer cases. Screening can be sporadic in these countries, causing cancer to often go undetected until it reaches an advanced stage. Global efforts and programs in individual countries are attempting to reduce the incidence and severity of cervical cancer through improved access to HPV vaccinations and self-testing for HPV infection.
December 20, 2022
Scientists look to decode the role of intestinal bacteria in our responses to immunotherapy.
December 20, 2022
LYMPHEDEMA IS A COMMON COMPLICATION of breast cancer treatment for patients who have lymph nodes removed or radiation to these areas. This chronic swelling, resulting from a buildup of lymph fluid, often occurs in the limbs. Once the swelling reaches a certain stage, lymphedema can’t be cured, so doctors focus on early detection and approaches, such as compression garments and lymphatic massage, to prevent progression.
December 16, 2022
Cytalux, an imaging agent developed at Purdue by researcher Phil Low, will improve the precision of surgery to remove lung cancer tumors. By attaching a fluorescent dye to a specific vitamin, surgeons can take advantage of a cancer cell's appetite to essentially highlight itself for removal. Low conducts his research as part of the Purdue Center for Cancer Research, bringing together more than 110 researchers who study cancer at the cellular level.
December 16, 2022
To address the overdose crisis in the United States, the National Institutes of Health has established a research network that will test harm reduction strategies in different community settings to inform efforts to help save lives. The harm reduction research network’s efforts build on existing harm reduction research, and represent the largest pool of funding from NIH to date to study harm reduction strategies to address overdose deaths.
